| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total other income, net | 642 | 4,582 | 5,768 | 6,891 |
| Loss before income taxes | -55,792 | -59,007 | -53,236 | -41,210 |
| Provision for income taxes | 0 | 0 | - | - |
| Net loss | -55,792 | -59,007 | -53,236 | -41,210 |
| Currency translation adjustment | 313 | 646 | -465 | - |
| Change in unrealized gain (loss) on available-for-sale securities | 501 | -225 | -493 | - |
| Comprehensive loss | -55,604 | -59,878 | -53,264 | - |
| Net loss per share attributable to common stockholders, basic | -0.16 | -0.17 | -0.16 | -0.15 |
| Net loss per share attributable to common stockholders, diluted | -0.16 | -0.17 | -0.16 | -0.15 |
| Weighted average common shares outstanding, basic | 342,393 | 340,746 | 338,612 | 273,565 |
| Weighted average common shares outstanding, diluted | 342,393 | 340,746 | 338,612 | 273,565 |
Nuvation Bio Inc. (NUVB)
Nuvation Bio Inc. (NUVB)